Max Wolf
Impact in
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 27
- Genetics 17
- Chronic Lymphocytic Leukemia Research 14
- Co-authors
- John F. Seymour (29 shared papers)H. Miles Prince (26 shared papers)Robert Marcus (6 shared papers)Marinus H. J. van Oers (6 shared papers)Anton Hagenbeek (6 shared papers)Eva Kimby (6 shared papers)M. van Glabbeke (6 shared papers)Richard Klasa (6 shared papers)
- Journals
- Blood (12 papers)Cancer (5 papers)Journal of Clinical Oncology (4 papers)The Medical Journal of Australia (2 papers)European Journal of Cancer (2 papers)
- Partner nations
- AustraliaUnited KingdomNetherlands
In The Last Decade
Max Wolf
55 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 77
- Pathology and Forensic Medicine 1.6k
- Genetics 653
- Oncology 812
- Neurology 368
- Hematology 186
Countries citing papers authored by Max Wolf
This map shows the geographic impact of Max Wolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Wolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Wolf more than expected).
Fields of papers citing papers by Max Wolf
This network shows the impact of papers produced by Max Wolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Wolf. The network helps show where Max Wolf may publish in the future.
Co-authors
The 25 scholars most cited alongside Max Wolf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 432 | |
| 2 | 2010 | 226 | |
| 3 | 2008 | 155 | |
| 4 | 2008 | 143 | |
| 5 | 2002 | 115 | |
| 6 | 2006 | 90 | |
| 7 | 2006 | 81 | |
| 8 | 2016 | 76 | |
| 9 | 2006 | 75 | |
| 10 | 2001 | 60 | |
| 11 | 2013 | 51 | |
| 12 | 2009 | 40 | |
| 13 | 2008 | 37 | |
| 14 | 2004 | 36 | |
| 15 | 2010 | 35 | |
| 16 | 2011 | 29 | |
| 17 | 2005 | 28 | |
| 18 | 1997 | 26 | |
| 19 | 2004 | 25 | |
| 20 | 2012 | 25 |
About Max Wolf
Max Wolf is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Hematology and Neurology, having authored 55 papers that have together received 2.1k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (27 papers), Chronic Lymphocytic Leukemia Research (14 papers), CNS Lymphoma Diagnosis and Treatment (9 papers), Viral-associated cancers and disorders (8 papers), Acute Lymphoblastic Leukemia research (6 papers), Multiple Myeloma Research and Treatments (5 papers), Protein Degradation and Inhibitors (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.6k citations), Genetics (653 citations), Oncology (812 citations), Neurology (368 citations) and Hematology (186 citations). Max Wolf has collaborated with scholars based in Australia, United Kingdom and Netherlands. Frequent co-authors include John F. Seymour, H. Miles Prince, Robert Marcus, Marinus H. J. van Oers, Anton Hagenbeek, Eva Kimby, M. van Glabbeke, Richard Klasa, Harald Holte and Andrej Vranovský. Their work appears in journals such as Blood, Cancer, Journal of Clinical Oncology, The Medical Journal of Australia and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.